AMISH PATEL, PhD

Dr. Patel has over 18 years of global biopharma and biotech leadership experience, providing strategic guidance throughout the entire biologic product life cycle where he has managed teams from 2 to 70+.  He understands the importance of hiring the right talent to build a strong team and nurturing that talent to make an impact on the global health space. 

 

Dr. Patel is currently the Vice President of Technical Operations at Calidi Biotherapeutics and is responsible for critical oversight of Global Manufacturing, Quality, and Supply Chain to produce Clinical and Commercial therapies utilizing Calidi’s innovative cell-based delivery of an oncolytic virus.

​

Over the course of his career, he has led the development of fifteen INDs, two commercial product approvals, and numerous PAS submissions. He was most recently the Senior Director of Product Development at Emergent BioSolutions (formerly PaxVax, Inc., prior to acquisition), where he successfully built and directed cross-functional teams working on numerous technology platforms. Dr. Patel has served on several in-license, out license, and mergers and acquisition deals.

 

He currently serves as a member of the UCI Customer Experience Advisory Board, and the global Operational Excellence Council, and frequently gives back to the scientific community by participating in NIH review panels.  He was also elected to the Technical Activities Committee in 2023 for the US National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST). 

​

Dr. Patel received Ph.D. in Engineering/Nanotechnology and MS in Chemical Engineering from Louisiana Tech University, Louisiana specializing in using nanotechnology tools for enzyme and DNA encapsulation and delivery funded by a NASA grant. He has Bachelors of Engineering in Chemical from Poona University, India.